Overview
Percutaneous mitral valve repair with the MitraClip® system has emerged as a therapeutic alternative to surgical valve repair (PMVR) in high risk patients.
The aim of this registry is to collect prospectively and systematically clinical research data from patients undergoing PMVR with the MitraClip® system. This registry is an open-end observational study to assess the characteristics and outcomes patients with severe mitral regurgitation undergoing PMVR.
Eligibility
Inclusion Criteria:
- severe mitral regurgitation
- percutaneous mitral valve repair (PMVR) with the MitraClip® system
Exclusion Criteria:
- < 18 years
- Patients considered by the heart team to be unlikely to receive meaningful or durable clinical benefit from the procedure